At a Glance
| Choline bitartrate | D-Serine | |
|---|---|---|
| Class | Nootropic | Nootropic, NMDA enhancer |
| Common Dose (oral) | 250–1000 mg | 1000–2000 mg |
| Total Duration | 3–5.8 hrs | 0.5–1.5 hrs |
| Routes | oral | Oral |
Choline bitartrate, a Nootropic, and D-Serine, a Nootropic, NMDA enhancer, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Choline bitartrate is classified as a Nootropic while D-Serine is a Nootropic, NMDA enhancer, meaning they approach altered states through different pharmacological mechanisms. They share 2 documented effects in common, with 7 effects unique to Choline bitartrate and 2 unique to D-Serine. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Choline bitartrate | D-Serine | |
|---|---|---|
| Class | Nootropic | Nootropic, NMDA enhancer |
| Common Dose (oral) | 250–1000 mg | 1000–2000 mg |
| Total Duration | 3–5.8 hrs | 0.5–1.5 hrs |
| Routes | oral | Oral |
| Effects |
| 9 documented |
| 4 documented |
| Level | Choline bitartrate | D-Serine |
|---|---|---|
| Threshold | 50 mg | — mg |
| Light | 100–250 mg | 500–1000 mg |
| Common | 250–1000 mg | 1000–2000 mg |
| Strong | 1000–2000 mg | 2000–4000 mg |
| Heavy | 2000 mg | 8000 mg |
Choline bitartrate
D-Serine
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.